Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8848 |
High Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD8053 |
Approved |
0.8521 |
High Similarity |
NPD8054 |
Approved |
0.8323 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD8252 |
Approved |
0.8323 |
Intermediate Similarity |
NPD8251 |
Approved |
0.8274 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.8221 |
Intermediate Similarity |
NPD6788 |
Approved |
0.8165 |
Intermediate Similarity |
NPD4584 |
Approved |
0.8101 |
Intermediate Similarity |
NPD2420 |
Approved |
0.8101 |
Intermediate Similarity |
NPD2421 |
Approved |
0.805 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.8013 |
Intermediate Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7987 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7879 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7843 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.7677 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7677 |
Intermediate Similarity |
NPD3109 |
Approved |
0.7677 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7662 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7654 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7643 |
Intermediate Similarity |
NPD7718 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7616 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7616 |
Intermediate Similarity |
NPD2970 |
Approved |
0.76 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD2898 |
Approved |
0.7572 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7572 |
Intermediate Similarity |
NPD27 |
Approved |
0.7558 |
Intermediate Similarity |
NPD6747 |
Phase 1 |
0.7548 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7531 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD6523 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7528 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7528 |
Intermediate Similarity |
NPD4577 |
Approved |
0.75 |
Intermediate Similarity |
NPD4663 |
Approved |
0.75 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7400 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7485 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD5156 |
Approved |
0.7473 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7473 |
Intermediate Similarity |
NPD6656 |
Clinical (unspecified phase) |
0.7469 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7457 |
Intermediate Similarity |
NPD4010 |
Discontinued |
0.7457 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7443 |
Intermediate Similarity |
NPD42 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD6042 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD4773 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD4772 |
Phase 2 |
0.743 |
Intermediate Similarity |
NPD7311 |
Approved |
0.743 |
Intermediate Similarity |
NPD7312 |
Approved |
0.743 |
Intermediate Similarity |
NPD7310 |
Approved |
0.743 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7425 |
Intermediate Similarity |
NPD4017 |
Approved |
0.7425 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD2200 |
Suspended |
0.7419 |
Intermediate Similarity |
NPD3595 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2606 |
Approved |
0.7419 |
Intermediate Similarity |
NPD2605 |
Approved |
0.7419 |
Intermediate Similarity |
NPD3594 |
Approved |
0.7412 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7412 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7396 |
Intermediate Similarity |
NPD7298 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7386 |
Intermediate Similarity |
NPD7493 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD5709 |
Phase 3 |
0.7378 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2233 |
Approved |
0.736 |
Intermediate Similarity |
NPD6996 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD3635 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3636 |
Approved |
0.7355 |
Intermediate Similarity |
NPD3637 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7046 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7341 |
Intermediate Similarity |
NPD4666 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1914 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7427 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7288 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4725 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4726 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4721 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD6607 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5303 |
Approved |
0.7267 |
Intermediate Similarity |
NPD5304 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD2568 |
Approved |
0.7247 |
Intermediate Similarity |
NPD6020 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7438 |
Suspended |
0.7226 |
Intermediate Similarity |
NPD4103 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD4104 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD8051 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD3639 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3641 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6030 |
Approved |
0.7202 |
Intermediate Similarity |
NPD6031 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3640 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7186 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD7030 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7176 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7161 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5754 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7143 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4257 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4256 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD3452 |
Approved |
0.712 |
Intermediate Similarity |
NPD3450 |
Approved |
0.712 |
Intermediate Similarity |
NPD2493 |
Approved |
0.712 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7108 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD7294 |
Phase 1 |
0.7104 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.7101 |
Intermediate Similarity |
NPD4727 |
Phase 1 |
0.7097 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2488 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4659 |
Approved |
0.7091 |
Intermediate Similarity |
NPD3060 |
Approved |
0.709 |
Intermediate Similarity |
NPD2973 |
Approved |
0.709 |
Intermediate Similarity |
NPD2975 |
Approved |
0.709 |
Intermediate Similarity |
NPD6284 |
Clinical (unspecified phase) |
0.709 |
Intermediate Similarity |
NPD2974 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7019 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7083 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7083 |
Intermediate Similarity |
NPD7020 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD7477 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD5238 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD4585 |
Approved |
0.7045 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.7044 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD2226 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD5938 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7035 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8005 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD3837 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD4583 |
Approved |
0.701 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7006 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD4237 |
Approved |
0.6987 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6982 |
Remote Similarity |
NPD3157 |
Approved |
0.6982
|
Remote Similarity |
NPD3158 |
Phase 1 |